Shree Pushkar Chemicals Q2 Profit Nearly Doubles; Rs 70 Crore Expansion Approved

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Shree Pushkar Chemicals Q2 Profit Nearly Doubles; Rs 70 Crore Expansion Approved

Shree Pushkar Chemicals & Fertilisers reported a 96% surge in Q2 net profit to Rs 35.72 crore, driven by a 58% revenue increase. To fuel future growth, the company announced a Rs 70 crore capex plan for a new chemical plant and a Rs 45 crore preferential warrant issue to the promoter.

Shree Pushkar Chemicals Q2 Profit Surges 96%

Revenue hits Rs 403.48 crore; Net profit climbs to Rs 35.72 crore.

Reader Takeaway: Strong operational momentum and promoter-backed growth funding signal long-term expansion despite pending project execution risks.

What just happened

Shree Pushkar Chemicals & Fertilisers Limited has posted impressive growth for the quarter ended September 30, 2026. Consolidated revenue grew by 58.17% YoY to Rs 403.48 crore, while net profit nearly doubled to Rs 35.72 crore compared to Rs 18.20 crore in the same quarter last year. Alongside these strong financial results, the board approved a major capital expenditure plan for its Unit-5 facility and a preferential issuance of warrants to the company's promoter.

Why this matters

The financial performance highlights improved operational efficiency and demand across the company's segments. By committing Rs 70 crore to a new 3,000 MTPA chemical plant in Maharashtra, the company is positioning itself to capture anticipated market demand. The decision by Chairman and Managing Director Punit Gopikishan Makharia to inject Rs 45 crore via preferential warrants signals strong promoter confidence in the long-term prospects of the company.

What changes now

The company is moving toward an EGM scheduled for December 2, 2026, to seek shareholder approval for these strategic initiatives. The funds raised through the warrant issuance are earmarked to support the ambitious capacity expansion, which is currently scheduled for commissioning by March 2028.

Risks to watch

Investors should consider the execution risks inherent in a project with a long gestation period stretching to March 2028. Managing cash flows during this multi-year construction phase and ensuring timely implementation of the Unit-5 plant will be critical to maintaining the growth trajectory.

What to track next

Shareholders should look for the outcome of the December 2 EGM and subsequent updates regarding the procurement and construction progress at the MIDC Lote Parshuram site in Maharashtra.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.